Simon D. Campion - 10 Jan 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role: President, CEO & Member of BOD, Director
Signature: /s/ Dane Baumgardner, Attorney-In-Fact for Simon D. Campion
Issuer symbol: XRAY
Transactions as of: 10 Jan 2025
Net transactions value: +$560
Form type: 4
Filing time: 14 Jan 2025, 16:14:06 UTC
Previous filing: 13 Nov 2024
Next filing: 05 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XRAY	Common Stock	Award	$0	+1,289	+0.47%	$0.000000	275,348	10 Jan 2025	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XRAY	Phantom Stock (Supplemental Executive Retirement Plan) SERP	Award	$560	+30	+0.86%	$18.51	3,526	10 Jan 2025	Common Stock	30		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2	Includes 309 shares acquired between July 1st - December 31, 2024 under the Dentsply Sirona Employee Stock Purchase Plan.
F3	Includes 644.0760 shares acquired through dividend reinvestment on 10/10/2024, Includes 858.853 shares acquired through dividend reinvestment on 1/10/2025.
F4	Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
F5	Comprised of phantom stock acquired as a result of accrued dividends.